{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T13:51:49Z","timestamp":1761486709892},"reference-count":14,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2001,12,21]],"date-time":"2001-12-21T00:00:00Z","timestamp":1008892800000},"content-version":"vor","delay-in-days":234,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tropical Med Int Health"],"published-print":{"date-parts":[[2001,5]]},"abstract":"<jats:p>Culture adapted <jats:italic>T. b. gambiense<\/jats:italic> isolated from Northwest Uganda were exposed to 0.001\u20130.14 \u03bcg\/ml melarsoprol or 1.56\u2013100 \u03bcg\/ml <jats:sc>DL<\/jats:sc>\u2010\u03b1\u2010difluoromethylornithine (DFMO). Minimum inhibitory concentrations (MICs) of each drug were scored for each isolate after a period of 10\u2003days drug exposure. The results indicate that <jats:italic>T. b. gambiense<\/jats:italic> isolates from Northwest Uganda had elevated MIC values for melarsoprol ranging from 0.009 to 0.072\u2003\u03bcg\/ml as compared with <jats:italic>T. b. gambiense<\/jats:italic> isolates from Cote d\u2018Ivoire with MIC values ranging from 0.001 to 0.018\u2003\u03bcg\/ml or with <jats:italic>T. b. rhodesiense<\/jats:italic> from Southeast Uganda with MIC values from 0.001 to 0.009\u2003\u03bcg\/ml. All MIC values obtained fell below expected peak melarsoprol concentrations in serum of treated patients. However, it may not be possible to maintain constant drug concentrations in serum of patients as was the case in our <jats:italic>in vitro<\/jats:italic> experiments. Importantly, the MIC of 0.072 \u03bcg\/ml exhibited by one of the isolates from Northwest Uganda was above levels attainable in CSF indicating that this isolate would probably not be eliminated from CSF of treated patients. PCR amplification of the gene encoding the P2\u2010like adenosine transporter followed by restriction digestion with <jats:italic>Sfa<\/jats:italic> NI enzyme revealed presence of fragments previously observed in a trypanosome clone with laboratory\u2010induced arsenic resistance. From our findings it appears that reduced drug susceptibility may be one factor for the frequent relapses of sleeping sickness after melarsoprol treatment occuring in Northwest Uganda.<\/jats:p>","DOI":"10.1046\/j.1365-3156.2001.00712.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T21:37:30Z","timestamp":1047505050000},"page":"407-411","source":"Crossref","is-referenced-by-count":56,"title":["Melarsoprol refractory <i>T. b. gambiense<\/i> from Omugo, north\u2010western Uganda"],"prefix":"10.1111","volume":"6","author":[{"given":"E.","family":"Matovu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. C. K.","family":"Enyaru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Legros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Schmid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Seebeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Kaminsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2001,12,21]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1159\/000239130"},{"key":"e_1_2_6_3_2","unstructured":"BurriC(1994)Pharmacological aspects of the trypanocidal drug melarsoprol. PhD thesis University of Basel Basel Switzerland."},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1038\/361173a0"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.2307\/3281038"},{"key":"e_1_2_6_6_2","first-page":"190","article-title":"Innate lack of susceptibility of Ugandan Trypanosoma brucei rhodesiense to DL\u2010difluoromethylorthine (DFMO)","volume":"46","author":"Iten M","year":"1995","journal-title":"Tropical Medicine and Parasitology"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-4894(89)90074-X"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-4894(70)90120-7"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0035-9203(99)90151-7"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/s004360050365"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.285.5425.242"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3156.1997.d01-122.x"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/0169-4758(93)90135-3"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/0001-706X(94)90013-2"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/0035-9203(92)90158-9"}],"container-title":["Tropical Medicine &amp; International Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-3156.2001.00712.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-3156.2001.00712.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T18:17:29Z","timestamp":1697566649000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-3156.2001.00712.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,5]]},"references-count":14,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2001,5]]}},"alternative-id":["10.1046\/j.1365-3156.2001.00712.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-3156.2001.00712.x","archive":["Portico"],"relation":{},"ISSN":["1360-2276","1365-3156"],"issn-type":[{"value":"1360-2276","type":"print"},{"value":"1365-3156","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,5]]}}}